Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Data are limited on the attributable outcomes of Clostridium diffi cile-associated disease (CDAD), particularly in CDAD-endemic settings.We conducted a retrospective cohort study of nonsurgical inpatients admitted for >48 hours in 2003 (N = 18,050).The adjusted hazard ratios for readmission (hazard ratio 2.19, 95% confi dence interval [CI] 1.87-2.55)and deaths within 180 days (hazard ratio 1.23, 95% CI 1.03-1.46)were signifi cantly different among CDAD case-patients and noncase patients.In a propensity score matched-pairs analysis that used a nested subset of the cohort (N = 706), attributable length of stay attributable to CDAD was 2.8 days, attributable readmission at 180 days was 19.3%, and attributable death at 180 days was 5.7%.CDAD patients were signifi cantly more likely than controls to be discharged to a long-term-care facility or outside hospital.Even in a nonoutbreak setting, CDAD had a statistically signifi cant negative impact on patient illness and death, and the impact of CDAD persisted beyond hospital discharge. C lostridium diffi cile-associated disease (CDAD) is anincreasingly common cause of hospital-associated diarrhea (1,2).The emerging NAP1 strain of C. diffi cile has been associated with numerous outbreaks and appears to be more virulent than other endemic and epidemic C. diffi cile strains (3-9).Despite the increasing importance of this pathogen, few data exist on outcomes attributable to CDAD (10-14).The attributable mortality for CDAD has recently been estimated at 6.9% and 16.7% (9,12).However, these studies were performed during CDAD outbreaks caused by the NAP1 strain.Published estimates of CDAD-attributable deaths in disease-endemic settings are much lower (1.2%-1.5%)(10,13).Kyne et al. did not fi nd endemic CDAD to be an independent predictor of death within 1 year of CDAD, but that study was relatively small (47 CDAD cases) (11).Thus, additional data with larger sample sizes are needed to determine outcomes associated with CDAD in nonoutbreak settings.With a large cohort of CDAD patients at a tertiary-care center, we evaluated CDAD outcomes including length of stay, hospital discharge status, time-to-readmission, and deaths in a CDADendemic setting. MethodsThis study was conducted at Barnes-Jewish Hospital (BJH), a 1,250-bed, tertiary-care academic hospital in St. Louis, Missouri.Eligibility was limited to nonsurgical patients admitted for >48 hours from January 1 through December 31, 2003.Nonsurgical patients were defi ned as those without operating room costs.Surgical patients were excluded because of their heterogeneity.Specifi cally, risk factors for length of stay, readmission to the hospital, and death were different in this population compared with other hospitalized patients.Data were primarily collected from the hospital's Medical Informatics database.The database was queried to collect patient demographics; admission and discharge dates; International Classifi cation of Diseases, 9th edition, Clinical Modifi cation (ICD-9-CM), diagnosis and procedure codes (online Appendix, available from www.cdc.gov/EID/content/14/7/1031-app.htm);inpatient medication orders; vital signs; and laboratory results, including C. diffi cile toxin assay results.The Medical Informatics database was also queried to ascertain date of death.Patients without a death date in the database were screened for death by reviewing the Social Security Death Index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · cited 1×
“In addition, the Charlson-Deyo method was used to classify co-existing conditions (16,17).”
MethodStatistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Cited by
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
Burden of Clostridium difficile on the Healthcare System
Dubberke, E. R., & Olsen, M. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis335 · Cited by 557
Self-citationTime interval of increased risk for Clostridium difficile infection after exposure to antibiotics
Hensgens, M. P. M., Goorhuis, A., Dekkers, O. M., & Kuijper, E. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr508 · Cited by 399
Hall, A. J., Curns, A. T., McDonald, L. C., Parashar, U. D., & Lopman, B. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis386 · Cited by 301
Self-citation
Metadata
- Authors
- Dubberke, E. R., Butler, A. M., Reske, K. A., Agniel, D., Olsen, M. A., D’Angelo, G., McDonald, L. C., & Fraser, V. J.
- Venue
- Emerging Infectious Diseases
- Published
- 2008-07
- Volume
- 14
- Issue
- 7
- Pages
- 1031-1038
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2082046334
- Cited by
- 152
- References
- 2
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients. https://app.cochat.ai/papers/10.3201/eid1407.070867
- The paper
- Dubberke, E. R., Butler, A. M., Reske, K. A., Agniel, D., Olsen, M. A., D’Angelo, G., McDonald, L. C., & Fraser, V. J. (2008). Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients. Emerging Infectious Diseases. https://doi.org/10.3201/eid1407.070867
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.